We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- Aim of the lecture
- Examples of autoimmune disease
- Single gene defects cause autoimmune pathology
- Factors governing the onset of autoimmunity
- The major histocompatibility complex (MHC)
- Genes outside the HLA region contribute to T1D
- Time course of type 1 diabetes
- Normal pancreas histology
- Type 1 diabetes - the autoimmune disease
- Immune mediated destruction of β cells
- Characteristics of type 1 diabetes
- MHC linkage and type 1 diabetes
- Type 1 diabetes
- NOD mouse: autoimmune prone inbred mouse
- MHC and type 1 diabetes
- The role of MHC class II molecules
- VNTR (INS)
- Environment
- Infection and type 1 diabetes (1)
- Environmental factors and T1D development
- Suggested causal link between T1D and infection
- Viral infections in type 1 diabetes
- Coxsackie virus capsid protein and T1D
- Infection and type 1 diabetes (2)
- Type 1 diabetes is on the increase
- Hygiene hypothesis
- T1D and neglected infectious diseases
- Co-evolution of parasite and host
- The ice man
- Schistosomiasis
- S. mansoni infection & soluble egg (SEA) or worm antigens (SWA) protect NOD mice from T1D
- Infectious agents affect other autoimmune conditions
- Other studies
- Pathology of different autoimmune diseases
- Targeting tolerance
- Therapeutic strategies
- Involvement of B cells
- Involvement of T cells
- Patients with T1D have CD8+ killer cells specific for preproinsulin in the blood (IFNγ ELISpot)
- Preproinsulin peptide administration experiments
- Non antigen specific manipulation of the immune response used in autoimmune disease
- Dose range of aglycosyl anti-CD3 & diabetes reversal
- Targets for intervention in T cell activation
- Three points for therapeutic intervention in T1D
- Thank You !
Topics Covered
- Autoimmune disease and associated genes
- Autoimmunity usually involves both genetic and environmental factors
- Genetic factors of Type 1 diabetes (T1D)
- environmental factors of T1D
- T1D and infection
- Infections can either initiate or inhibit onset of autoimmunity
- Understanding disease mechanism in order to develop a rational therapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Cooke, A. (2021, January 31). Autoimmunity and type 1 diabetes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/IJGK2112.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Emerita Anne Cooke has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Anne Cooke and I'm Emeritus Professor of
Immunobiology in the Pathology Department at the University of Cambridge.
Today I'm going to be talking to you about "Autoimmunity and Type 1 Diabetes".
0:14
The aim of the lecture is to examine
factors governing the development of autoimmune disease
and I'm really going to emphasize
type 1 diabetes because that's actually what I work on mainly.
0:27
Examples of autoimmune disease,
which you have probably seen in textbooks.
People have actually usually split them into organ-specific leading down to systemic.
But in fact, obviously,
there are some overlaps between these.
A classic organ-specific disease would be Grave's disease,
or Hashimoto's disease or thyroid disease,
where the autoimmune destruction is targeted to the thyroid gland.
At the other end of the spectrum,
the systemic lupus erythematosus,
sometimes known as SLE,
where the immune response is targeted to DNA,
proteins associated with DNA,
and obviously that's distributed throughout your whole body.
1:05
Now one thing which is important to recognize is,
although most autoimmune diseases are under polygenic control,
that is, under complex genetic control.
Some single gene defects can cause autoimmune pathology.
Fas/FasL ligand deficient humans will develop autoimmune lymphoproliferative syndrome,
sometimes known as ALPS, A-L-P-S,
characterized by defective lymphocyte apoptosis.
These individuals have splenomegaly, lymphadenopathy, and autoimmunity,
which is often where they have autoantibodies to DNA and DNA-associated proteins.
Individuals who have caspase 8 or caspase 10 deficiency,
have impaired apoptosis of their T-cells,
and they have symptoms similar to the ALPS patients, this lymphoproliferative syndrome.
Now AIRE, the autoimmune regulator is
a gene where mutations cause the recessively inherited disorder,
autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy,
otherwise known as APECED,
or also known as autoimmune polyendocrinopathy syndrome 1, APS1.
Patients with a deficiency in Foxp3 develop IPEX,
which is a polyendocrine autoimmune condition.
Patients with CD25 deficiency can have an autoimmune enteropathy and type 1 diabetes.
Individuals have any defects in TCR signaling molecules such as phosphorylation defects,
these can lead to autoimmune disorders characterized by
antinuclear antibodies as in SLE and nephritis.
People often get nephritis or
kidney disease because of immune complex depositions in the kidney.
Patients with cytokine deficiencies such as IL-10,
IL-10 receptor can develop inflammatory bowel disease or arthritis.
You can see these mimicked in animal models as well.
The factors that govern the onset of autoimmunity,